1. Home
  2. XLO vs AMPG Comparison

XLO vs AMPG Comparison

Compare XLO & AMPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

XLO

Xilio Therapeutics Inc.

N/A

Current Price

$9.04

Market Cap

56.9M

Sector

Health Care

ML Signal

N/A

Logo Amplitech Group Inc.

AMPG

Amplitech Group Inc.

HOLD

Current Price

$3.39

Market Cap

99.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
XLO
AMPG
Founded
2016
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
56.9M
99.7M
IPO Year
2021
2012

Fundamental Metrics

Financial Performance
Metric
XLO
AMPG
Price
$9.04
$3.39
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
★ $28.00
$7.00
AVG Volume (30 Days)
9.2K
★ 696.3K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 69.44
EPS
N/A
★ N/A
Revenue
★ $43,766,000.00
$25,195,930.00
Revenue This Year
N/A
$102.41
Revenue Next Year
$168.77
$20.00
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 589.88
164.99
52 Week Low
$0.46
$1.64
52 Week High
$9.90
$10.11

Technical Indicators

Market Signals
Indicator
XLO
AMPG
Relative Strength Index (RSI) 48.64 39.81
Support Level $8.63 $3.28
Resistance Level $9.15 $3.58
Average True Range (ATR) 0.24 0.13
MACD 0.00 0.08
Stochastic Oscillator 21.83 33.71

Price Performance

Historical Comparison
XLO
AMPG

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

About AMPG Amplitech Group Inc.

AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. It operates in two segments: the manufacturing and engineering segment. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.

Share on Social Networks: